Rockefeller Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-375
| Closed | – | – | 4227 |
|
|
2022
Q4 | $0 | Sell |
375
-6,000
| -94% | – | ﹤0.01% | 4376 |
|
|
2022
Q3 | $7K | Buy |
6,375
+2,000
| +46% | +$2.2K | ﹤0.01% | 3253 |
|
|
2022
Q2 | $7K | Sell |
4,375
-1,125
| -20% | -$1.8K | ﹤0.01% | 3335 |
|
|
2022
Q1 | $11K | Sell |
5,500
-500
| -8% | -$1K | ﹤0.01% | 3022 |
|
|
2021
Q4 | $16K | Sell |
6,000
-4,000
| -40% | -$10.7K | ﹤0.01% | 2770 |
|
|
2021
Q3 | $44K | Sell |
10,000
-7,800
| -44% | -$34.3K | ﹤0.01% | 2201 |
|
|
2021
Q2 | $103K | Buy |
17,800
+4,300
| +32% | +$24.9K | ﹤0.01% | 1788 |
|
|
2021
Q1 | $94K | Buy |
13,500
+12,674
| +1,534% | +$88.2K | ﹤0.01% | 1627 |
|
|
2020
Q4 | $3K | Buy |
826
+326
| +65% | +$1.18K | ﹤0.01% | 2606 |
|
|
2020
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 2438 |
|
|
2020
Q2 | $3K | Hold |
500
| – | – | ﹤0.01% | 2280 |
|
|
2020
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 2134 |
|
|
2019
Q4 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 1803 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1946 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 926 |
|